ALLOSURE
AlloSure is the first and only non-invasive test that assesses organ health by directly measuring allograft injury. AlloSure can accurately determine active rejection, enabling better management of your kidney transplant patients.AlloSure is a clinically and analytically validated, non-invasive blood test that measures donor-derived cell-free DNA (dd-cfDNA), an indicator of kidney injury.
ALLOSURE
Industry:
Health Care Medical
Website Url:
http://www.allosure.com
Status:
Active
Technology used in webpage:
SPF Mobile Non Scaleable Content DNSSEC DMARC Microsoft Exchange Online Apache Office 365 Mail PHP 7 Common Name Invalid CPanel
Similar Organizations
Allista Chronic Care Solutions
A premier service of comfort and convenience for the repatriation of migrants with severe work-related injuries.
Assaf Harofeh Medical Center
Assaf Harofeh Medical Center is a company that provides an array of medical services to patients.
genom
genom is the most convenient way to contact the laboratory, that is, without leaving home.
IBStreatment
IBS Treatment is achieved by controlling bowel bacteria, Diarrhea after eating changing diet and repairing the gut wall with nutrients.
Navis Medical Technology
Navis Medical Technology is an organization that delivers a mobile health solution to patients.
Pure Vitamen
Pure Vitamen That palpate move can be a strategy with again apply which frequently hardens inside limiting our skin.
Youly
Youly is an online hassle-free women's healthcare platform.
Official Site Inspections
http://www.allosure.com
- Host name: 62.115.215.35.bc.googleusercontent.com
- IP address: 35.215.115.62
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "AlloSure"
Understanding and using AlloSure donor derived cell-free DNA
This review considers the utility of AlloSure, a donor derived cell free DNA molecular surveillance tool, which has shown new clinical insights on how best to manage renal transplant patients, …See details»
AlloSure Plus AI-Derived Post-Transplant Rejection Status - CareDx
AlloSure Plus is an AI-derived kidney transplant risk prediction algorithm powered by AlloSure. See the probability of a patient’s allograft rejection.See details»
AlloSure Sample Collection and Draw Instructions
See our resources section below for instructions on drawing the AlloSure sample, preparing the order form, and packaging and shipping the sample.See details»
Understanding the Allosure Test for Kidney …
One such method is the Allosure test, a non-invasive procedure that utilizes donor-specific cell-free DNA to assess the health of kidney transplants. …See details»
SEC.gov
The Company’s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (“dd-cfDNA”) solution for kidney transplant patients, AlloMSee details»
AlloSure - Crunchbase Company Profile & Funding
AlloSure is the first and only non-invasive test that assesses organ health by directly measuring allograft injury.See details»
AlloWrap® - AlloSource
AlloWrap is a human amniotic membrane designed to act as a biologic barrier following surgical repair to assist the body in minimizing adhesions …See details»
Donor-Derived Cell-Free DNA: Is It All the Same? The Jury Is Still Out
In this study, the currently published threshold of 1% to define positivity of AlloSure yielded sensitivity of 45% (five of 11), lower than the 59% reported in the Circulating Donor-Derived …See details»
Legal - alluresecurity
Jul 23, 2024 If you are using the Services on behalf of an organization, you are agreeing to the Agreement on behalf of that organization and representing that you have the authority to bind …See details»
AlloSure for Kidney Transplant Rejection - evicore.com
Jan 1, 2025 The available studies evaluating AlloSure Kidney provide limited evidence regarding the validity of the test for detecting renal graft rejection.15-25 Several studies have shown an …See details»
Epic - Showroom
In kidney transplant, our AlloSure test was the first donor-derived cell-free DNA (dd-cfDNA) test for transplant patients and remains the most studied and validated test of its kind. A recent …See details»
Whois allosure.com
Whois Lookup for allosure.comUpdated 1 second ago Domain Information Domain: allosure.com Registrar: GoDaddy.com, LLC Registered On: 2015-10-29 Expires On: 2025-10-29 Updated …See details»
CareDx Launches Two Expanded Indications for AlloSure Testing
Mar 11, 2025 AlloSure Heart, available for patients aged 15 years and older since 2020, is now clinically validated and commercially available for use in pediatric patients under 15, including …See details»
CareDx Announces New Data on AlloSure Lung Presented at 2025 ...
Apr 29, 2025 Surveillance monitoring using AlloSure Lung effectively identified rising dd-cfDNA levels signaling onset of acute cellular rejection and decline in levels after treatment for …See details»
AVAILABLE NOW A clear path forward
AlloSure, innovation in action AlloSure is clinically and analytically validated, non-invasive donor-derived cell-free DNA (dd-cfDNA) test for identifying kidney injury.See details»
Transplants: blood test to test for rejection - Mayo Clinic Connect
May 22, 2022 Hi Transplants, Has anyone had a blood test to test for signs of rejection? The one my nephrologist suggested is called Allosure by CareDx as an alternative tool to be used as a …See details»
Donor-Derived Cell-Free DNA (dd-cfDNA) for Detection of …
Donor-derived cell-free DNA (dd-cfDNA) is used to detect antibody-mediated rejection in transplant recipients, providing a non-invasive method for monitoring organ transplant health.See details»
Predicting Kidney Transplant Rejection | Cedars-Sinai
She and her team requested permission to use a test designed to detect rejection in adult kidney transplant patients. The adult test, known as Allosure, looks for detection of donor-derived, cell …See details»
AlloSure | “The AlloSure test completely changed for me what the …
“The AlloSure test completely changed for me what the future really has been like with this kidney transplant. It was just such a praise report from me.”...See details»
CareDx Announces Landmark KOAR Study Published in the …
Aug 6, 2025 The landmark prospective study demonstrates the clinical utility of AlloSure® donor-derived cell-free DNA (dd-cfDNA) in improving rejection detection and guiding biopsy …See details»